Cocrystal Pharma Balance Sheet Health
Financial Health criteria checks 4/6
Cocrystal Pharma has a total shareholder equity of $12.7M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $16.2M and $3.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$13.02m |
| Equity | US$12.70m |
| Total liabilities | US$3.53m |
| Total assets | US$16.23m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 8CC's short term assets ($14.3M) exceed its short term liabilities ($1.9M).
Long Term Liabilities: 8CC's short term assets ($14.3M) exceed its long term liabilities ($1.6M).
Debt to Equity History and Analysis
Debt Level: 8CC is debt free.
Reducing Debt: 8CC had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 8CC has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: 8CC has less than a year of cash runway if free cash flow continues to reduce at historical rates of 24.5% each year